Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/25 08:06 | 3/18/25 | ARVN | Health | Drug | Pharmaceutical Preparations | Berkowitz Noah | CT | O | Chief Me | 1 | S | -74 | 8.59 | 0 | -9 | 110 | D | |||||||||||||||
2/25/25 06:37 | 2/24/25 | ARVN | Health | Drug | Pharmaceutical Preparations | Loomis David K | CT | O | Chief Ac | 1 | S | -20 | 16.75 | 0 | -1 | 19 | D | |||||||||||||||
2/25/25 06:35 | 2/24/25 | ARVN | Health | Drug | Pharmaceutical Preparations | Cacace Angela M | CT | O | Chief Sc | 1 | S | -70 | 16.70 | 0 | -4 | 97 | D | |||||||||||||||
2/25/25 06:33 | 2/24/25 | ARVN | Health | Drug | Pharmaceutical Preparations | Taylor Ian | CT | O | P,R,D | 1 | S | -151 | 16.71 | 0 | -9 | 159 | D | |||||||||||||||
2/25/25 06:31 | 2/24/25 | ARVN | Health | Drug | Pharmaceutical Preparations | Houston John G | CT | DO | P,CEO | 1 | S | -524 | 16.72 | 0 | -31 | 1,157 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |